God is our Guide  cidpusa No -1 in autoimmune diseases prevention , treatment and inflammation
cidpusa.org

 CIDPUSA Foundation 

 
Home
Diagnosis
Treatment
Pathology
Women Heart Risk
Women Killer Disease
Fibrmomyalgia
IVIG
Diet anti-inflammatory
Burning Feet Home
Services Page
Hepatitis
Autoimmune diseases
Prognosis
Bible healing
Pemphagoid

Polio  Vaccine  Guidelines

 Oral Polio vaccine

  Polio in Nigeria

Vaccine causes polio

Polio drops cause death

Azospermia

Natural Makeup
Neck Pain
Ocular Female diseases
Chronic fatigue syndrome
Osteoporosis
Women Heart Attacks
Spices
Cure all diseases
Vinegar
Memory problems
Breast Lymph Drainage
Kidney stone Buster
Bras cause breast cancer
Skin repair Clinic
Pandas
Hepatitis
Clinics of Excellence

  heart disease & stroke 

  Memory clinic

Depression & anxiety

addiction  & Drug Rehab

Sexual  disorders Clinic

Parkinson Clinic

Epilepsy Clinic

Pain Clinic

Bone disorders clinic

Joint disorder clinic

Skin repair clinic

Neurology Clinic

TMJ CLINIC

      Reduce weight

Prevent Osteoporosis

Pollution

  Chronic pain

 MS GENES

 Polymyalgia

 Achalasia

 

 

                         Polio Virus , vaccine the details

  For treatments of autoimmune  disorders please read our e-book  
 
 
 

  

 

 

Poliovirus Vaccine

 
 

 

 

 

 

 

In September 2005, an unvaccinated 7-month-old infant with severe combined immunodeficiency in an Amish community without vaccine coverage for polio was diagnosed with poliovirus by stool sample. The type 1 poliovirus was identified as a vaccine-derived poliovirus from oral poliovirus vaccine (OPV). Three other children in the household had the same virus recovered from stool samples, although the children were not ill. Vaccine-derived poliovirus occurs via replication in an immunocompromised patient or via circulating virus in communities with low vaccine coverage; therefore, the risk for transmission to other low-vaccination communities and for an outbreak in the United States is heightened.[9]

Incidence

Prevaccination cases of poliovirus reached a peak in 1952 with more than 21,000 cases of paralytic disease.[10] In the United States, the last known case of wild virus polio infection occurred in 1979.[10,11]

For the year 2005, the number of countries with endemic polio decreased from 7 to 4 compared with 2002 and from 125 compared with 1988.[12] Eight countries that were polio-free were reinfected, although transmission has been reduced in all except Somalia. These 8 countries were Angola, Bangladesh, Chad, Ethiopia, Indonesia, Nepal, Somalia, and Yemen. Polio remains endemic in 3 Asian countries -- Afghanistan, India, and Pakistan. Routine vaccination coverage for infants is estimated at 80% worldwide varying from 69% in Africa to 94% in Europe. Worldwide there were 1948 virus-confirmed cases of polio in 2005, with none reported in America, Europe, or the Western Pacific.[13]

One risk for infection is contact with low-vaccinated communities.[9] There is a risk for vaccine-associated paralytic poliomyelitis (VAPP) seen with the live attenuated poliovirus vaccine. The risk is estimated at 1 in 2.4 million does of OPV, with first-dose risk of 1 in 750,000.[11,14] The last case of VAPP in the United States was in 1999.[10]

Pathogenesis

Poliovirus is an RNA picornavirus and enterovirus.[10] A highly contagious virus, it is spread from person to person by the fecal-to-oral route by contact with stool, contaminated sewage or water, oral secretions, or fomites.[9] After exposure, the virus replicates in the oropharynx and intestine with a resultant viremia that can infect the central nervous system. There are 3 serotypes -- 1, 2 and 3 -- with most infections caused by type 1, type 3, and type 2 in that order. The incubation period is 6-20 days (range, 3-35), and infectivity lasts 4-6 weeks. More than 90% of household contacts of an individual with wild poliovirus infection become infected. Humans are the only reservoir, and infection results in lifelong immunity.[10,14] Long-term carriage can occur in immunodeficient individuals, but is otherwise rare.[14] Poliovirus peaks in the summer months for temperate climates with no seasonal variation in tropical zones.[10]

Clinical Manifestations

The majority, up to 95%, of poliovirus infections are asymptomatic. Some infections, 4% to 8%, present as a mild febrile illness that may take the form of an upper respiratory tract infection, a gastrointestinal illness, or a flulike illness. Finally, 1% to 2% present as a mild prodromal illness followed by aseptic meningitis. Less than 1% or 1 in 200 infections result in acute flaccid paralysis, with a 2- to 3-day prodromal illness followed in 1-10 days by an asymmetric paralysis.[9-11,14] The virus has an affinity for anterior horn cells and the brainstem, resulting in spinal (79% of cases), bulbar (2%), or a combination disease (19%).[10,14] Maximum paralysis occurs in 2-4 days with fever and muscle pain. Most patients recover muscle function. Persistent weakness or paralysis 12 months post infection is usually permanent.[10]

The case-fatality rate for paralytic illness is 2% to 5% for children, 15% to 30% for adults, and 25% to 75% for bulbar disease.[10] Postpolio syndrome, consisting of muscle pain and progressive or new weakness or paralysis, occurs in 25% to 40% of individuals infected in childhood and presents 30-40 years after initial infection, and is related to wild poliovirus infections.[14]

For Diagnosis page click here to continue

 

 continue to page-2 of coconut oil benefits

 

 

 
 
service for health emotional physcial freedom